Sleep-related disorders in chronic obstructive pulmonary disease

Expert Review of Respiratory Medicine

Volumn 8, Issue 1, 2014, Pages 79-88

  Crinion, Sophie J ^a,b   McNicholas, Walter T ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

cardiovascular co morbidity; COPD; hypoxemia; inflammation; obstructive sleep apnea; pathophysiology; sleep

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ADAPTATION; ARTERIAL STIFFNESS; BREATHING; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; GAS EXCHANGE; HUMAN; HYPERCAPNIA; HYPOVENTILATION; HYPOXEMIA; INFLAMMATION; LUNG MINUTE VOLUME; OXYGEN DESATURATION; OXYGEN THERAPY; PHYSIOLOGICAL PROCESS; PRESSURE SUPPORT VENTILATION; PULMONARY HYPERTENSION; REM SLEEP; RESPIRATORY FAILURE; REVIEW; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY;

COMORBIDITY; DISEASE MANAGEMENT; FATIGUE; HUMANS; HYPERTENSION, PULMONARY; HYPOVENTILATION; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SLEEP DISORDERS;

EID: 84893152767     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2014.860357     Document Type: Review

References (94)

1. Ellenbogen JM. Cognitive benefits of sleep and their loss due to sleep deprivation. Neurology 64(7), E25-E27 (2005).
2. Sagaspe P, Sanchez-Ortuno M, Charles A. et al.: Effects of sleep deprivation on Color-Word, Emotional, and Specific Stroop interference and on self-reported anxiety. Brain Cogn. 60(1), 76-87 (2006).
3. McNicholas WT. Impact of sleep in COPD. Chest 117(2 Suppl.), S48-S53 (2000).
4. Agusti A, Hedner J, Marin JM, Barbe F, Cazzola M, Rennard S. Night-Time symptoms: A forgotten dimension of COPD. Eur. Respir. Rev. 20(121), 183-194 (2011).
5. McSharry DG, Ryan S, Calverley P, Edwards JC, McNicholas WT. Sleep quality in chronic obstructive pulmonary disease. Respirology 17(7), 1119-1124 (2012).
6. Rennard S, Decramer M, Calverley PM. et al.: Impact of COPD in North America and Europe in 2000: Subjects' perspective of Confronting COPD International Survey. Eur. Respir. J. 20(4), 799-805 (2002).
7. Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW. Respiration during sleep in normal man. Thorax 37(11), 840-844 (1982).
8. McNicholas WT. Impact of sleep in respiratory failure. Eur. Respir. J. 10(4), 920-933 (1997).
9. Johnson MW, Remmers JE. Accessory muscle activity during sleep in chronic obstructive pulmonary disease. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 57(4), 1011-1017 (1984).
10. Hetzel MR, Clark TJ. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 35(10), 732-738 (1980).
11. Hudgel DW, Devadatta P. Decrease in functional residual capacity during sleep in normal humans. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 57(5), 1319-1322 (1984).
12. Breslin E, Schans Cvd, Breukink S. et al.: Perception of Fatigue and Quality of Life in Patients With COPD. Chest 114(4), 958-964 (1998).
13. Cormick W, Olson L, Hensley M, Saunders N. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax 41, 846-854 (1986).
14. Klink M, Quan S. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest 91, 540-546 (1987).
15. Klink ME, Dodge R, Quan SF. The relation of sleep complaints to respiratory symptoms in a general population. Chest 105(1), 151-154 (1994).
16. Sanders MH, Newman AB, Haggerty CL. et al.: Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am. J. Respir. Crit. Care Med. 167(1), 7-14 (2003).
17. Saaresranta T, Irjala K, Aittokallio T, Polo O. Sleep quality, daytime sleepiness and fasting insulin levels in women with chronic obstructive pulmonary disease. Respir. Med. 99(7), 856-863 (2005).
18. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 28(2), 193-213 (1989).
19. Soler X, Diaz-Piedra C, Ries AL. Pulmonary rehabilitation improves sleep quality in chronic lung disease. COPD 10(2), 156-163 (2013).
20. Kwon JS, Wolfe LF, Lu BS, Kalhan R. Hyperinflation is associated with lower sleep efficiency in COPD with co-existent obstructive sleep apnea. COPD 6(6), 441-445 (2009).
21. Hedemark LL, Kronenberg RS. Ventilatory and heart rate responses to hypoxia and hypercapnia during sleep in adults. J. Appl. Physiol. 53(2), 307-312 (1982).
22. Phillips BA, Cooper KR, Burke TV. The effect of sleep loss on breathing in chronic obstructive pulmonary disease. Chest 91(1), 29-32 (1987).
23. Becker HF, Piper AJ, Flynn WE. et al.: Breathing during sleep in patients with nocturnal desaturation. Am. J. Respir. Crit. Care Med. 159(1), 112-118 (1999).
24. Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J. Isolated nocturnal desaturation in COPD: Prevalence and impact on quality of life and sleep. Thorax 64(2), 133-138 (2009).
25. Fletcher EC, Donner CF, Midgren B. et al.: Survival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest 101(3), 649-655 (1992).
26. McNicholas WT, Fitzgerald MX. Nocturnal deaths among patients with chronic bronchitis and emphysema. Br. Med. J. (Clin. Res. Ed.) 289(6449), 878 (1984).
27. Hudgel DW, Martin RJ, Capehart M, Johnson B, Hill P. Contribution of hypoventilation to sleep oxygen desaturation in chronic obstructive pulmonary disease. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 55(3), 669-677 (1983).
28. Mulloy E, McNicholas WT. Ventilation and gas exchange during sleep and exercise in severe COPD. Chest 109(2), 387-394 (1996).
29. Shepard JW Jr, Schweitzer PK, Keller CA, Chun DS, Dolan GF. Myocardial stress. Exercise versus sleep in patients with COPD. Chest 86(3), 366-374 (1984).
30. Fletcher EC, Luckett RA, Miller T, Costarangos C, Kutka N, Fletcher JG. Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleep. Chest 95(4), 757-764 (1989).
31. Owens RL. Supplemental oxygen needs during sleep. Who benefits? Respir. Care 58(1), 32-47 (2013).
32. White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV. Sleep deprivation and the control of ventilation. Am. Rev. Respir. Dis. 128(6), 984-986 (1983).
33. Downey R, Bonnet MH. Performance during frequent sleep disruption. Sleep 10(4), 354-363 (1987).
34. Omachi TA, Blanc PD, Claman DM. et al.: Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 13(5), 476-483 (2012).
35. Ito K, Kawayama T, Shoji Y. et al.: Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease. Respirology 17(6), 940-949 (2012).
36. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea. Eur. Respir. J. 8(7), 1161-1178 (1995).
37. Redolfi S, Yumino D, Ruttanaumpawan P. et al.: Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men. Am. J. Respir. Crit. Med. 179(3), 241-246 (2009).
38. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am. Rev. Respir. Dis. 139(6), 1435-1438 (1989).
39. McNicholas WT, Calverley PM, Lee A, Edwards JC. Long-Acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur. Respir. J. 23(6), 825-831 (2004).
40. Mulloy E, McNicholas W T. Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest 101(3), 753-757 (1992).
41. Lee R, McNicholas WT. Obstructive sleep apnea in chronic obstructive pulmonary disease patients. Curr. Opin. Pulm. Med. 17(2), 79-83 (2011).
42. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: Overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am. J. Respir. Crit. Care Med. 180(8), 692-700 (2009).
43. Bednarek M, Plywaczewski R, Jonczak L, Zielinski J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: A population study. Respiration 72(2), 142-149 (2005).
44. Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 151(1), 82-86 (1995).
45. Greenberg-Dotan S, Reuveni H, Tal A. et al.: Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea. Sleep Breath (2013) (Epub ahead of print).
46. Gottlieb DJ, Yenokyan G, Newman AB. et al.: Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The sleep heart health study. Circulation 122(4), 352-360 (2010).
47. Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome. Am. J. Respir. Crit. Care Med. 182(3), 325-331 (2010).
48. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352(16), 1685-1695 (2005).
49. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336(14), 973-979 (1997).
50. Miller M, Zhan M, Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: The Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 165(18), 2063-2068 (2005).
51. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112(17), 2660-2667 (2005).
52. Shamsuzzaman AS, Winnicki M, Lanfranchi P. et al.: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21), 2462-2464 (2002).
53. Yokoe T, Minoguchi K, Matsuo H. et al.: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8), 1129-1134 (2003).
54. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-Analysis. Thorax 59(7), 574-580 (2004).
55. Karadag F, Kirdar S, Karul AB, Ceylan E. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur. J. Intern. Med. 19(2), 104-108 (2008).
56. Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 186(6), 403-409 (2008).
57. de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C. et al.: C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur. Respir. J. 27(5), 902-907 (2006).
58. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 175(3), 250-255 (2007).
59. Agusti A. Systemic effects of chronic obstructive pulmonary disease: What we know and what we don't know (but should). Proc. Am. Thorac. Soc. 4(7), 522-525 (2007).
60. Nural S, Gunay E, Halici B, Celik S, Unlu M. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36(1), 66-74 (2013).
61. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 131(5), 1557-1566 (2007).
62. Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92(3), 347-355 (2004).
63. Shiina K, Tomiyama H, Takata Y. et al.: Overlap syndrome: Additive effects of COPD on the cardiovascular damages in patients with OSA. Respir. Med. 106(9), 1335-1341 (2012).
64. Fletcher EC, Schaaf JW, Miller J, Fletcher JG. Long-Term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am. Rev. Respir. Dis. 135(3), 525-533 (1987).
65. Sajkov D, Wang T, Saunders NA, Bune AJ, Neill AM, Douglas Mcevoy R. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am. J. Respir. Crit. Care Med. 159(5 Pt 1), 1518-1526 (1999).
66. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Martinez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: Effects of continuous positive airway pressure: A randomized, controlled cross-over study. Eur. Heart J. 27(9), 1106-1113 (2006).
67. Sharma B, Neilan TG, Kwong RY. et al.: Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea. COPD 10(1), 4-10 (2013).
68. Goldstein RS, Ramcharan V, Bowes G, McNicholas WT, Bradley D, Phillipson EA. Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N. Engl. J. Med. 310, 425-429 (1984).
69. Moloney ED, Kiely JL, McNicholas WT. Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease. Lancet 357(9255), 526-528 (2001).
70. Costello RW, Liston R, McNicholas WT. Compliance at night with low flow oxygen therapy: A comparison of nasal cannulae and Venturi face masks. Thorax 50(4), 405-406 (1995).
71. Martin RJ, Bartelson BL, Smith P. et al.: Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest 115(5), 1338-1345 (1999).
72. Ryan S, Doherty LS, Rock C, Nolan GM, McNicholas WT. Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease. Respiration 79(6), 475-481 (2010).
73. Aubier M, De Troyer A, Sampson M, Macklem PT, Roussos C. Aminophylline Improves Diaphragmatic Contractility. N. Engl. J. Med. 305(5), 249-252 (1981).
74. Mulloy E, McNicholas WT. Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 148, 1030-1036 (1993).
75. Beghè B, Rabe KF, Fabbri LM. Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases. Am. J. Respir. Crit. Care Med. 188(3), 271-278 (2013).
76. Roth T. Hypnotic use for insomnia management in chronic obstructive pulmonary disease. Sleep Med. 10(1), 19-25 (2009).
77. Steens R, Pouliot Z, Millar T, Kryger M, George C. Effects of Zolpidem and Triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 16, 318-326 (1993).
78. Kryger M, Roth T, Wang-Weigand S, Zhang J. The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease. Sleep Breath 13(1), 79-84 (2009).
79. Kapella MC, Herdegen JJ, Perlis ML. et al.: Cognitive behavioral therapy for insomnia comorbid with COPD is feasible with preliminary evidence of positive sleep and fatigue effects. Int. J. Chron. Obstruct. Pulmon. Dis. 6, 625-635 (2011).
80. Lloyd-Owen SJ, Donaldson GC, Ambrosino N. et al.: Patterns of home mechanical ventilation use in Europe: Results from the Eurovent survey. Eur. Resp. J. 25(6), 1025-1031 (2005).
81. Schonhofer B, Kohler D. Effect of non-invasive mechanical ventilation on sleep and nocturnal ventilation in patients with chronic respiratory failure. Thorax 55(4), 308-313 (2000).
82. Elliott MW, Mulvey DA, Moxham J, Green M, Branthwaite MA. Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: Mechanisms underlying changes in arterial blood gas tensions. Eur. Resp. J. 4(9), 1044-1052 (1991).
83. Goldstein RS, De Rosie JA, Avendano MA, Dolmage TE. Influence of noninvasive positive pressure ventilation on inspiratory muscles. Chest 99(2), 408-415 (1991).
84. Meecham Jones DJ, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am. J. Respir. Crit. Care Med. 152(2), 538-544(1995).
85. Renston JP, DiMarco AF, Supinski GS. Respiratory muscle rest using nasal BiPAP ventilation in patients with stable severe COPD. Chest 105(4), 1053-1060 (1994).
86. Díaz-Lobato S, Alises SM, Rodriguez EP. Current status of noninvasive ventilation in stable COPD patients. Int. J. Chron. Obstruct. Pulmon. Dis. 1(2), 129-135 (2006).
87. Casanova C, Celli BR, Tost L. et al.: Long-Term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 118(6), 1582-1590 (2000).
88. Clini E, Sturani C, Rossi A. et al.: The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur. Resp. J. 20(3), 529-538 (2002).
89. Jones SE, Packham S, Hebden M, Smith AP. Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: Long term follow up and effect on survival. Thorax 53(6), 495-498 (1998).
90. Budweiser S, Jörres RA, Riedl T. et al.: Predictors of survival in copd patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest 131(6), 1650-1658 (2007).
91. McEvoy RD, Pierce RJ, Hillman D. et al.: Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: A randomised controlled trial. Thorax 64(7), 561-566 (2009).
92. Tsolaki V, Pastaka C, Karetsi E. et al.: One-year non-invasive ventilation in chronic hypercapnic COPD: Effect on quality of life. Respir. Med. 102(6), 904-911 (2008).
93. Struik FM, Lacasse Y, Goldstein R, Kerstjens HM, Wijkstra PJ. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 6, CD002878 (2013).
94. Toraldo D, De Nuccio F, Nicolardi G. Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): A 24-month follow-up study. Sleep Breath 14(2), 115-123 (2010).